These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15161059)

  • 1. The inflammatory response to cardiopulmonary bypass: a therapeutic overview.
    Rubens FD; Mesana T
    Perfusion; 2004; 19 Suppl 1():S5-12. PubMed ID: 15161059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of systemic inflammatory response after cardiac surgery.
    Raja SG; Dreyfus GD
    Asian Cardiovasc Thorac Ann; 2005 Dec; 13(4):382-95. PubMed ID: 16304234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-coated cardiopulmonary bypass circuits: current status.
    Hsu LC
    Perfusion; 2001 Sep; 16(5):417-28. PubMed ID: 11565897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin.
    Harig F; Feyrer R; Mahmoud FO; Blum U; von der Emde J
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):111-8. PubMed ID: 10363611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomaterial development for cardiopulmonary bypass.
    Gourlay T
    Perfusion; 2001 Sep; 16(5):381-90. PubMed ID: 11565893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies.
    Wan S; LeClerc JL; Vincent JL
    Chest; 1997 Sep; 112(3):676-92. PubMed ID: 9315800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic inflammation and cardiac surgery: an update.
    Asimakopoulos G
    Perfusion; 2001 Sep; 16(5):353-60. PubMed ID: 11565890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiopulmonary bypass technology transfer: musings of a cardiac surgeon.
    Rubens FD
    J Biomater Sci Polym Ed; 2002; 13(4):485-99. PubMed ID: 12160305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key Points for Curbing Cardiopulmonary Bypass Inflammation.
    Evora PR; Bottura C; Arcêncio L; Albuquerque AA; Évora PM; Rodrigues AJ
    Acta Cir Bras; 2016; 31 Suppl 1():45-52. PubMed ID: 27142905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the inflammatory response to cardiopulmonary bypass in children.
    Kozik DJ; Tweddell JS
    Ann Thorac Surg; 2006 Jun; 81(6):S2347-54. PubMed ID: 16731102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inflammatory response and haematological disorders in cardiac surgery: toward a more physiological cardiopulmonary bypass].
    Baufreton C; Corbeau JJ; Pinaud F
    Ann Fr Anesth Reanim; 2006 May; 25(5):510-20. PubMed ID: 16488106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. eComment: Re: The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
    Bockeria LA; Grigoryants RG
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):99. PubMed ID: 19122158
    [No Abstract]   [Full Text] [Related]  

  • 13. Biocompatibility in cardiopulmonary bypass.
    Hsu LC
    J Cardiothorac Vasc Anesth; 1997 May; 11(3):376-82. PubMed ID: 9161907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericardial suction blood separation attenuates inflammatory response and hemolysis after cardiopulmonary bypass.
    Skrabal CA; Khosravi A; Choi YH; Kaminski A; Westphal B; Steinhoff G; Liebold A
    Scand Cardiovasc J; 2006 Aug; 40(4):219-23. PubMed ID: 16914412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
    Senay S; Toraman F; Gunaydin S; Kilercik M; Karabulut H; Alhan C
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):93-9. PubMed ID: 18801802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population.
    Durandy Y
    Artif Organs; 2014 Jan; 38(1):11-8. PubMed ID: 24392866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Currently available biomaterials for use in cardiopulmonary bypass.
    Belway D; Rubens FD
    Expert Rev Med Devices; 2006 May; 3(3):345-55. PubMed ID: 16681456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating.
    Seeburger J; Hoffmann J; Wendel HP; Ziemer G; Aebert H
    Circulation; 2005 Aug; 112(9 Suppl):I224-8. PubMed ID: 16159821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.
    Sohn N; Marcoux J; Mycyk T; Krahn J; Meng Q
    Perfusion; 2009 Jul; 24(4):231-7. PubMed ID: 19858237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.